Correlation Between Phio Pharmaceuticals and First Wave

Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and First Wave at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and First Wave into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Phio Pharmaceuticals Corp and First Wave BioPharma, you can compare the effects of market volatilities on Phio Pharmaceuticals and First Wave and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of First Wave. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and First Wave.

Diversification Opportunities for Phio Pharmaceuticals and First Wave

0.54

Correlation Coefficient

Phio Pharmaceuticals  First Wave

Very weak diversification

The 3 months correlation between Phio and First is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and First Wave BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Wave BioPharma and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with First Wave. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Wave BioPharma has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and First Wave go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and First Wave

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to generate 3.09 times more return on investment than First Wave. However, Phio Pharmaceuticals is 3.09 times more volatile than First Wave BioPharma. It trades about -0.04 of its potential returns per unit of risk. First Wave BioPharma is currently generating about -0.87 per unit of risk. If you would invest  2,390  in Phio Pharmaceuticals Corp on September 12, 2024 and sell it today you would lose (2,109) from holding Phio Pharmaceuticals Corp or give up 88.24% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	1.14%
Values	Daily Returns

Phio Pharmaceuticals Corp  vs.  First Wave BioPharma

Phio Pharmaceuticals Corp

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Phio Pharmaceuticals Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Phio Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

First Wave BioPharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days First Wave BioPharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, First Wave is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Phio Pharmaceuticals and First Wave

The main advantage of trading using opposite Phio Pharmaceuticals and First Wave positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, First Wave can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Wave will offset losses from the drop in First Wave's long position.

The idea behind Phio Pharmaceuticals Corp and First Wave BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.